<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">

  <head>
    <title>Special Blood Components</title>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="stylesheet" href="http://code.jquery.com/mobile/1.4.4/jquery.mobile-1.4.4.min.css" />
    <link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css">
    <link rel="stylesheet" href="app.css">
    <link href="http://themergency.com/footable-demo/css/footable-0.1.css" rel="stylesheet" type="text/css" />
    <link href="http://themergency.com/footable-demo/css/footable.sortable-0.1.css" rel="stylesheet" type="text/css" />
  </head>

  <body>
    
    <div class="overlay">
    	
    	<div class="overlay-container" id="terms">
        <h3 class="headerlogo"><i class="fa fa-ln glow">&#xf043;</i> Special Blood Components Terms of Use
        </h3>
    		<div class="textbox">
        <p><strong>
    		 By pressing the 'Accept and continue' button, you indicate that you have
    		 read and consent to the Terms of Use.</strong>
    		</p>
    		<h3>Terms of Use</h3>
        <p>
          Special Blood Components ("the app") was created during a PhD research project 
          at the University of Edinburgh and is available for evaluation only. 
          It aims to make it easy to learn about the correct use of irradiated and
          cytomegalovirus (CMV) negative blood components. The app is designed for:
        </p>
        <ul>
          <li>Doctors who prescribe and request blood transfusions.
          </li>
          <li>Nurses and midwives who administer or prescribe transfusions.
          </li>
          <li>Biomedical scientists who process blood requests.
          </li>
          <li>Medical trainees who may be required to undertake any of the above.
          </li>
        </ul>
        
        <h4>
          Evidence base
        </h4>
        
        <p>
          The app is based on (but in no way endorsed by) the British Committee for
          Standards in Haematology (BCSH) 2010 guidelines on the irradation of blood
          components and the 2012 position statement on the use of CMV negative blood
          components by the Advisory Committee on the Safety of Blood, Tissues and Organs
          (SaBTO). Recommendations for irradiated and CMV negative blood components is
          displayed in the app when it is indicated in these national UK guidelines.
        </p>
        
        <h4>
          Disclaimer
        </h4>
        
        <p>
          The developers and contributors cannot be held liable for any harm 
	        resulting from the use of the app. There may be inaccuracies in the content.
	        Guidance may not be appropriate in all patient situations. Local hospital 
	        policies may differ. The app is not intended to be a substitute for
          local hospital guidelines, professional medical judgement, advice, diagnosis, or treatment.
        </p>
        
        
        <h4>
          Data protection
        </h4>
        
        <p>
          The app is developed for a research project seeking to evaluate and improve the design
          of clinical apps. The use of the app is therefore monitored using Google Analytics.
          The following data is recorded:
        </p>
        
        <ul> 
          <li>Which pages you visit and for how long.</li>
          <li>Information about your computing device (operating system, screen resolution, browser, IP address).</li>
          <li>Your approximate geographical location (country, city).</li>
          <li>Keywords that you input in the app's search functionality.</li>
        </ul>
        
	      <p style="display:none">
          If you choose to provide additional feedback (using the 'leave feedback' button), we 
          may correlate your browsing behaviour with your feedback answers to help
          us better understand the strengths and weaknesses of the app design. To do this we 
          store a browser cookie on your device.
          We do not collect personally identifying information unless you choose to
          disclose this through the online feedback form.
        </p>
        
        <h4>No warranty</h4>
        
        <p>
          THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
          IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
          FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
          AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
          LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
          OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
          SOFTWARE.
        </p>
    		</div>
    		<a href="#" onclick="$('.overlay').slideUp('slow');" class="ui-btn ui-shadow ui-corner-all ui-btn-a">Accept and continue</a>
  		</div>
  	</div>
  	
  	
    <div data-role="page" id="home" data-title="Special Blood Components">
      
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf043;</i> Special Blood Components Home
        </h3>
        <div class="submenu inactive">
          <a href="#about" data-role="button" class="float-left"><i class="fa fa-ln">&#xf05a;</i> About</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
    
    		<h2 style="display:none" class="mainlogo">
    		  <i class="fa fa-5x glow">&#xf043;</i>
          <br/>Special Blood Components
        </h2>

        <a data-role="button" href="#learn" class="infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf19d;</i>
           <strong>Learn</strong><br/>
           Improve your knowledge of special blood components.
        </a>
        
        <a data-role="button" href="#indications" class="infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf02d;</i>
           <strong>Indications</strong><br/>
           Who require irradiated and <span class="explanation" title="Cytomegalovirus">CMV</span> negative blood components?
        </a>
        
        <a data-role="button" href="#searchpanel" class="infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf002;</i>
           <strong>Search the app</strong><br/>
           Enter a search term or look up a word in the index.
        </a>
        
        <a data-role="button" href="#about" class="infobox">
           <i class="fa fa-2x button-icon">&#xf05a;</i>
           <strong>About the app</strong><br/>
           Find out more details about this app.
        </a>
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab active"><i class="fa fa-2x glow">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab inactive"><i class="fa fa-2x">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="learn" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1. Introduction
        </h3>
        <div class="submenu inactive">
          <a href="#home" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn2" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        <h2>1. Introduction</h2>
        <ul>
          <li>Learning outcomes</li>
          <li>Summary of key points</li>
          <li>TA-GvHD and irradiation</li>
          <li>CMV infection and screening</li>
          <li>Mistakes and their prevention</li>
          <li>Test your knowledge</li>
          <li>Glossary</li>
          <li>Learning resources</li>
          <li>References</li>
        </ul>
        <h3>
          1.1 Patient safety
        </h3>
        <p>
          Failure to provide <a href="javascript:%20showWord('irradiation')" class=
          "definition">irradiated</a> cellular <a href=
          "javascript:%20showWord('components')" class="definition">blood components</a>
          may expose <a href="javascript:showWord('at-risk')" class="definition">at-risk
          patients</a> to transfusion-associated Graft versus Host Disease <a href=
          "javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a>. This is a very
          rare, but life-threatening condition <a href=
          "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010, p.37</a>.
        </p>
        <p>
          Red cells and platelets supplied through the UK Blood Services are <a href=
          "javascript:%20showWord('leucodepletion')" class="definition">leucocyte
          depleted</a> <a href="javascript:%20showSource('bcsh2010');" class=
          "reference">SaBTO 2012, p.1</a>. However removal of leucocytes (white cells) is
          not a substitute for irradiation, which prevents TA-GvHD by inactivating residual
          donor lymphocytes <a href="javascript:%20showSource('bcsh2010');" class=
          "reference">BCSH 2010, p.49</a>.
        </p>
        <p>
          Although leucodepletion provides significant protection against <a href=
          "javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a> (CMV)
          infection, cellular blood components should be provided as CMV negative to
          protect vulnerable patients against transfusion-transmitted CMV infection
          <a href="javascript:%20showSource('sabto2012');" class="reference">SaBTO
          2012</a>.
        </p>
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="learn2"  data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.2 Mistakes
        </h3>
        <div class="submenu inactive">
          <a href="#learn" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn3" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.2 Mistakes
        </h3>
        <p>
          Almost three million blood components are issued annually in UK <a href=
          "javascript:%20showSource('shot2009');" class="reference">SHOT 2009, p.11</a>.
          Of these, approximately 10% are irradiated <a href=
          "javascript:%20showSource('shot2010');" class="reference">SHOT 2010, p.129</a>.
        </p>
        <p>
          In the last five years, more than five hundred mistakes involving irradiated
          and CMV negative blood components were reported to the Serious Hazards of
          Transfusion (SHOT) UK haemovigilance scheme (Figure 1).
        </p>
        <p>
          These were incidents where blood components failed to be provided as irradiated
          and/or CMV negative to at-risk patients according to guidelines.
        </p><img src="http://optimalblooduse.eu/app/graph.png" style="display: block; margin: 0 auto; width:100%;" />
        <p style="line-height: 1.1em;">
          <b>Figure 1:</b> Specific Requirements Not Met (SRNM) reports by year and
          source of error. Clinical errors include failure to communicate the need for
          special components to the lab. Lab errors are when the request was made but not
          acted upon <a href="javascript:%20showSource('shot2010');" class=
          "reference">SHOT 2010, p.27</a>. SHOT data used with permission and provided
          courtesy of Dr. Paula Bolton-Maggs, Debbi Poles and Alison Watts.
        </p>
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    <div data-role="page" id="learn3" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.3 Causes
        </h3>
        <div class="submenu inactive">
          <a href="#learn2" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn4" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.3 Causes
        </h3>
        <p>
          There are many underlying reasons for why special requirements fail to be
          provided to at-risk patients, as these SHOT cases illustrate:
        </p>
        
        <div data-role="collapsible-set" data-theme="f" data-content-theme="f">
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>
              Poor knowledge of the indications
            </h3>
            <p>
              "The admitting doctor noted the past history of Hodgkin's disease but was
              not aware of the requirements for irradiated blood." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2011,
              p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>
              Request form not filled out correctly
            </h3>
            <p>
              "A request form for blood components for a patient with CLL on fludarabine
              was completed by a haematology nurse, and checked and signed by a junior
              doctor who also prescribed the components. The need for irradiated blood
              was not indicated on the request form or the prescription." <a href=
              "javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.46</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>
              Failure to check medical record
            </h3>
            <p>
              "An elderly man was transfused 9 units of blood for chronic anaemia.
              Subsequently a haematology registrar found that he had been treated with
              cladarabine several years before." <a href=
              "javascript:%20showSource('shot2012');" class="reference">SHOT 2012,
              p.32</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>
              Shared patient care
            </h3>
            <p>
              "A patient was transferred from his primary hospital, where he had
              undergone a stem-cell transplant, to another hospital within the same Trust
              in order to access an ITU bed. [...] Irradiated components were not
              requested due to a lack of communication between the clinicians, and the
              laboratory records were separate from those at the originating hospital."
              <a href="javascript:%20showSource('shot2010');" class="reference">SHOT
              2010, p.41</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>
              Wrong blood component transfused
            </h3>
            <p>
              "No patient identification was taken to the blood fridge, and as a result
              the wrong unit of red cells was removed by a registered nurse and taken to
              the ward for an 81-year-old female patient with chronic lymphocytic
              leukaemia (CLL). On the ward another nurse administering the transfusion
              assumed that the checks had been completed, and because of this assumption
              no bedside checks were performed. The patient received non-irradiated group
              A D positive red cells, instead of irradiated O D positive red cells. The
              error was noticed when the patient asked whether the unit was irradiated.
              Consequently &lt;50 mL was transfused." <a href=
              "javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.31</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>
              Incorrect use of warning flags
            </h3>
            <p>
              "A patient required irradiated blood because of previous chemotherapy. The
              transfusion laboratory had received notification of this special
              requirement and added the information to the LIMS. The special requirement
              flag was subsequently removed from the LIMS in error. From the time the
              flag was removed to the time it was discovered, the patient had received 15
              units of red cells and 5 units of platelets that had not been irradiated."
              <a href="javascript:%20showSource('shot2012');" class="reference">SHOT
              2012, p.56</a>
            </p>
          </div>
        </div>
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
      
    <div data-role="page" id="learn4" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.4 Prevention
        </h3>
        <div class="submenu inactive">
          <a href="#learn3" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn5" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.4 Prevention
        </h3>
        <p>
          SHOT has made several recommendations aimed at reducing mistakes. Some of these are to:
        </p>
        <div data-role="collapsible-set" data-theme="h" data-content-theme="h">
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Increase knowledge of special requirements
            </h3>
            <p>
              "All haematology units must devise specific educational programmes for all
              their staff members providing the rationale and indications for specialist
              components and this information should be accessible at the time of making
              the requests for blood components." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2011,
              p.28</a>
            </p>
            <p>
              "The importance of irradiation, and the rationale behind it should be
              emphasised during teaching of junior haematology and oncology doctors. This
              education is part of the curriculum for specialist trainees, but the junior
              pre-specialist doctors in these areas may remain ignorant despite being
              frequently called upon to order components." <a href=
              "javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Ensure special blood components are ordered correctly
            </h3>
            <p>
              "Local mechanisms for ordering and prescribing components need to
              facilitate correct ordering, and remind clinical and laboratory personnel
              where possible" <a href="javascript:%20showSource('shot2011');" class=
              "reference">SHOT 2011, p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Educate patients who have special requirements
            </h3>
            <p>
              "Patients who require irradiated and other special products should be
              provided with an appropriate card [...] Patients with cards noting special
              requirements should be educated about their meaning and importance, in
              particular always to show these to clinical staff on admission to any
              hospital." <a href="javascript:%20showSource('shot2012');" class=
              "reference">SHOT 2012, p.34</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Conduct thorough bedside checks
            </h3>
            <p>
              "The final 'bedside' check is the last opportunity to ensure that the
              correct unit or component has been collected for the patient receiving the
              transfusion. Complete and thorough bedside checks involving one or two
              staff members must be completed independently and without interruption. "
              <a href="javascript:%20showSource('shot2011');" class="reference">SHOT
              2013, p.61</a>
            </p>
            <p>
              "Every person in the transfusion process must perform rigorous identity
              checks at each point and ensure that the component collected is the one
              prescribed. The use of a transfusion checklist is recommended." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2013,
              p.62</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Use warning flags with care
            </h3>
            <p>
              "Computer prompts/warnings/flags are a valuable tool for trying to prevent
              human error through 'slips'; but staff must also have the underpinning 
              knowledge to understand and act appropriately to a warning." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2012,
              p.7</a>
            </p>
            <p>
              "The addition of these warnings/flags/notes is a manual procedure and is
              itself prone to error and should be controlled, for example, entered by one
              BMS and checked by a second." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2012,
              p.51</a>
            </p>
          </div>
        </div>
        <p>
          Press to expand list items.
        </p>
        <p>
          For more details and recommendations, please refer to the latest SHOT
          report. <a href="javascript:%20showSource('shot2013');" class=
          "reference">SHOT 2013</a>
        </p>
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="learn5" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.5 Glossary
        </h3>
        <div class="submenu inactive">
          <a href="#learn4" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn6" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.5 Glossary
        </h3>
        
        <div data-role="collapsible-set" data-inset="true" data-theme="a" data-content-theme="b" id="glossaryCollection">
          <div data-role="collapsible" id="at-risk">
            <h3>
              At-risk patients
            </h3>
            <p>
              Please consult the list of indications to determine which patient groups
              are considered at risk of transfusion-associated <a href=
              "javascript:%20showWord('gvhd')" class="definition">Graft versus Host
              Disease</a> (TA-GvHD) and transfusion-transmitted <a href=
              "javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a>
              (CMV) infection.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="#list" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Indications</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="components">
            <h3>
              Blood components
            </h3>
            <p>
              Blood is separated into five components: red cells, platelets, white cells,
              fresh frozen plasma and cryoprecipitate <a href=
              "javascript:%20showSource('htm2007')" class="reference">HTM 2007, p. 1</a>.
              These can be classified into cellular and non-cellular (plasma) components.
            </p>
            <h3>
              Cellular blood components
            </h3>
            <p>
              Platelets, red cells and white cells are cellular blood components that
              contain leucocytes (white cells).
            </p>
            <p>
              Lymphocytes (a type of white cell) can cause <a href=
              "javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a>. Hence
              cellular blood components, even if <a href=
              "javascript:%20showWord('leucodepletion')" class=
              "definition">leucodepleted</a>, must be <a href=
              "javascript:%20showWord('irradiation')" class="definition">irradiated</a>
              to deactivate any residual lymphocytes before transfusion to <a href=
              "javascript:%20showWord('at-risk')" class="definition">at-risk patients</a>
              <a href="javascript:%20showSource('htm2007')" class="reference">HTM 2007,
              p. 41</a>.
            </p>
            <p>
              The only exception to this rule is cryopreserved red cells after
              deglycerolization, because these are washed free of leucocytes <a href=
              "javascript:%20showSource('bcsh2010')" class="reference">BCSH 2010, p.
              42</a>.
            </p>
            <p>
              Monocytes (another type of white cell) may carry latent <a href=
              "javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a>
              (CMV). For this reason SaBTO recommend cellular blood components be
              provided leucodepleted and CMV negative to high risk patients <a href=
              "javascript:%20showSource('sabto2012')" class="reference">SaBTO 2012</a>.
            </p>
            <h3>
              Non-cellular (plasma) blood components
            </h3>
            <p>
              In contrast, fresh frozen plasma, cryoprecipitate or fractionated plasma
              products are non-cellular blood components that do not contain white cells.
            </p>
            <p>
              Non-cellular blood components do not need to be irradiated or provided as
              CMV negative (even though CMV can occurr freely in plasma) <a href=
              "javascript:%20showSource('sabto2012')" class="reference">SaBTO 2012, p.
              2</a>.
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="cmv">
            <h3>
              Cytomegalovirus (CMV)
            </h3>
            <p>
              "Cytomegalovirus is a herpes virus that gives rise to chronic, persistent
              and, for the most part, asymptomatic infection in a majority of adults
              worldwide. More severe disease may occur in certain groups, such as
              foetuses, neonates and immunocompromised adults." <a href=
              "javascript:%20showSource('sabto2012');" class="reference">SaBTO 2012</a>
            </p>
            <p>
              "Cytomegalovirus (CMV) infection can cause serious morbidity in
              immunocompromised CMV-negative patients. The risk can be minimised by the
              use of CMV-antibody-negative (seronegative) blood components. <a href=
              "javascript:%20showWord('leucodepletion')" class="definition">Leucocyte
              depletion</a> also confers some protection since the virus is associated
              with white blood cells." <a href="javascript:%20showSource('htm2007');"
              class="reference">HTM 2007, p. 41</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="relatives">
            <h3>
              First- or second-degree relatives
            </h3>
            <p>
      	      "The 'degree of relationship' describes the proportion of genes shared by two 
              blood relatives. A person's first degree relative is a parent, sibling,  or 
              child. A first degree relative shares about half of their genes with the person.
      	    </p>
      	    <p>
      	      A second degree relative of a person is an uncle, aunt, nephew, niece, 
              grandparent, grandchild or half- sibling.  A second degree relative shares about
              one quarter of their genes with the person." <a href="javascript:%20showSource('nhsgenetics');" class="reference">NHS NGGEC no year</a>.
            </p>
            <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="irradiation">
            <h3>
              Irradiation
            </h3>
            <p>
              "The major technology for preventing <a href=
              "javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a> is
              irradiation of blood components to inactivate residual lymphocytes. Gamma
              rays and X-rays are similar in their ability to inactivate T lymphocytes in
              blood components at a given absorbed dose." <a href=
              "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.41</a>
            </p>
            <p>
              "In the UK, a minimum of 25 Gy is recommended, but with the dose to any bag
              in the container not exceeding 50 Gy. To ensure this dose distribution is
              achieved, consultation with supporting physicists is mandatory." <a href=
              "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.41</a>
            </p>
            <p>
              "For at-risk patients, all red cell, platelet and granulocyte concentrates
              should be irradiated except cryopreserved red cells after
              deglycerolization. It is not necessary to irradiate fresh frozen plasma,
              cryoprecipitate or fractionated plasma products (1B)." <a href=
              "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.36</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="leucodepletion">
            <h3>
              Leucodepletion
            </h3>
            <p>
              Red cells and platelets supplied through the UK blood services are
              leucocyte depleted <a href="javascript:%20showSource('bcsh2010');" class=
              "reference">SaBTO 2012, p.1</a>.
            </p>
            <p>
              "Removal of leucocytes to a level of less than one million per component by
              filtration or during collection of blood components by apheresis is normal
              practice in a number of EU countries. Advantages of leucodepletion include
              a marked reduction in alloimmunisation to HLA antigens and in the risk of
              infection by intracellular viruses such as cytomegalovirus. Leucodepletion
              of red cells may also be associated with improved outcomes in some groups
              of patients." <a href="javascript:%20showSource('obu2010');" class=
              "reference">OBU 2010</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="gvhd">
            <h3>
              Transfusion-Associated Graft versus Host Disease
            </h3>
            <p>
              "TA-GvHD is a very rare but usually fatal complication following
              transfusion of lymphocyte-containing blood components. [---] The risk
              associated with an individual transfusion depends on the number and
              viability of contaminating lymphocytes, susceptibility of the
              recipient's immune system to their engraftment and degree of 
              immunological (HLA) disparity between donor and patient."
              <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH
              2010, p.37</a>
            </p>
            <p>
              "Transfused donor lymphocytes which are compatible with the recipient, but
              which recognise the recipient as foreign, can engraft and initiate TA-GvHD.
              Patients develop skin rash, diarrhoea and abnormal liver function, and
              deteriorate, with bone marrow failure and death from infection usually
              within two to three weeks of transfusion." <a href=
              "javascript:%20showSource('htm2007');" class="reference">HTM 2007, p.41</a>
            </p>
            <p>
              "Patients at risk are immunocompromised or those who receive transfusion
              from a first- or second-degree relative (due to the sharing of an HLA
              haplotype)." <a href="javascript:%20showSource('htm2007');" class=
              "reference">HTM 2007, p.62</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
        </div>
        <p>
          Press to expand an entry.
        </p>
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    <div data-role="page" id="learn6" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.6 References
        </h3>
        <div class="submenu inactive">
          <a href="#learn5" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.6 References
        </h3>
        
        <div data-role="collapsible-set" data-theme="a" data-content-theme="b"
        data-inset="true" id="referenceCollection">
          <div data-role="collapsible" id="bcsh2010">
            <h3>
              BCSH (2010)
            </h3>
            <p>
              Treleaven, J., Gennery, A., Marsh, J., Norfolk, D., Page, L., Parker, A.,
              Saran, F., Thurston, J. and Webb, D. (2011), Guidelines on the use of
              irradiated blood components prepared by the British Committee for Standards
              in Haematology blood transfusion task force. British Journal of
              Haematology, 152: 35-51. doi: 10.1111/j.1365-2141.2010.08444.x
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08444.x/full"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="htm2007">
            <h3>
              HTM (2007)
            </h3>
            <p>
              DBL McClelland (ed) (2007) Handbook of Transfusion Medicine, 4th Ed.
              Published in the UK by The Stationary Office.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "http://www.transfusionguidelines.org.uk/index.aspx?Publication=HTM"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="mesh2013">
            <h3>
              MESH (2013)
            </h3>
            <p>
              Medical Subject Headings (2013) published by the U.S. National Library of
              Medicine, National Institutes of Health.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.nlm.nih.gov/mesh/2013/mesh_browser/" target="_blank"
                data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme=
                "b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="nhsgenetics">
            <h3>
              NHS NGGEC (no year)
            </h3>
            <p>
              NHS National Genetics and Genomics Education Centre,
              glossary item "First-degree relative".
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.geneticseducation.nhs.uk/genetics-glossary/181-first-degree-relative" target="_blank"
                data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme=
                "b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="obu2010">
            <h3>
              OBU (2010)
            </h3>
            <p>
              McClelland DBL, Pirie E, Franklin IM (2010) for the EU Optimal Use of Blood
              Project Partners. The Optimal Blood Use Manual. Published by Scottish
              National Blood Transfusion Service.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.optimalblooduse.eu" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="sabto2012">
            <h3>
              SaBTO (2012)
            </h3>
            <p>
              Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)
              (2012) Position statement on cytomegalovirus tested blood components.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "https://www.gov.uk/government/publications/sabto-report-of-the-cytomegalovirus-steering-group"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2008">
            <h3>
              SHOT (2008)
            </h3>
            <p>
              Taylor C, Cohen H, Jones H, et al (2008), on behalf of the Serious Hazards
              of Transfusion (SHOT) Steering Group. The 2007 Annual SHOT Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/reports-and-summaries-2007/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2009">
            <h3>
              SHOT (2009)
            </h3>
            <p>
              Taylor C (Ed.), Cohen H, Mold D, Jones H, et al (2009), on behalf of the
              Serious Hazards of Transfusion (SHOT) Steering Group. The 2008 Annual SHOT
              Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/reports-and-summaries-2008/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2010">
            <h3>
              SHOT (2010)
            </h3>
            <p>
              Taylor C (Ed.), Cohen H, Mold D, Jones H, et al (2010), on behalf of the
              Serious Hazards of Transfusion (SHOT) Steering Group. The 2009 Annual SHOT
              Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/report-and-summary-2009/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2012">
            <h3>
              SHOT (2012)
            </h3>
            <p>
              Bolton-Maggs, P (Ed) and Cohen, H (2012) on behalf of the Serious Hazards
              of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/shot-annual-report-summary-2011/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2013">
            <h3>
              SHOT (2013)
            </h3>
            <p>
              Bolton-Maggs P (Ed), Poles D, Watt A, Thomas D and Cohen H (2013) on behalf
              of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2012
              Annual SHOT Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/report-summary-and-supplement-2012/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="ukbts2012">
            <h3>
              UKBTS (2012)
            </h3>
            <p>
              Joint UKBTS / HPA Professional Advisory Committee (2012) Position Statement
              on Granulocyte Therapy. Revised by Edwin Massey, Simon Stanworth and
              Rebecca Cardigan at the request of the Standing Advisory Committee on Blood
              Components.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "http://www.transfusionguidelines.org.uk/index.aspx?Publication=DL&amp;pageid=1336"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
        </div>
        <p>
          Press to expand an entry. All documents open in a new window.
        </p>
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="indications" data-title="Indications for irradiated and CMV negative blood components">
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf02d;</i> Indications for irradiated and CMV negative blood components
        </h3>
        <div class="submenu inactive">
          <a href="#" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#" data-role="button" class="ui-state-disabled float-left" data-rel="back">Next <i class="fa fa-ln">&#xf054;</i></a>
          <a href="#searchpanel" data-role="button">Find <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>
      <div role="main" class="ui-content">
        
        <button data-inline="true" data-icon="search" onclick="$('#indicationsearch').toggle();$(this).toggleClass('ui-icon-minus').toggleClass('ui-icon-search');">Search the indications table</button>
        <div id="indicationsearch" style="display: none">
          <input id="filter" type="search" />
          <a href="#" onclick="$('table').trigger('footable_filter', {filter: 'granulocyte'});" data-inline="true" data-role="button">Gran</a>
          <a href="#" onclick="$('table').trigger('footable_clear_filter');" data-inline="true" data-role="button">Clear filter</a>
        </div>
        <table class="footable" id="indicationstable" data-filter="#filter">
          <thead>
            <tr>
              <th data-class="expand">Indication
              </th>
              <th data-hide="phone" data-type="numeric">Irradiation
              </th>
              <th data-hide="phone" data-type="numeric">CMV-negative
              </th>
              <th data-hide="all"></th>
            </tr>
          </thead>
          <tbody>
            <tr class="bloodcomponent">
              <td>1. Blood from a relative of the patient.</td>
              <td data-value="3">
                <p class="redcell"> <i class="fa fa-warning fa-2x red"></i>
                  <br/>Irradiation required.</p>
              </td>
              <td data-value="1">
                <p class="greencell">CMV-negative not required, unless neonate, pregnant woman or granulocyte transfusion.</p>
              </td>
              <td>"All transfusions from <a href="#rels" data-rel="popup" style="color: inherit; text-decoration: underline; text-decoration-style: dotted; font-weight: inherit;">first- or second-degree relatives <i class="fa fa-info-circle"></i></a> should be irradiated, even if the patient is immunocompetent (1B)."
                <div data-role="popup" id="rels">
                  <p>This is a completely basic popup, no options set.</p>
                </div>
              </td>
            </tr>
            <tr class="bloodcomponent">
              <td>2. Granulocytes.</td>
              <td data-value="3">
                <p class="redcell"><i class="fa fa-warning fa-2x"></i>
                  <br/>Irradiation required.</p>
              </td>
              <td data-value="2">
                <p class="ambercell"><i class="fa fa-warning fa-2x"></i>
                  <br/>CMV-negative required for CMV-negative patients.</p>
              </td>
              <td>
                <p>1. "All granulocyte transfusions should be irradiated for recipients of any age, and they should be transfused soon as possible after irradiation. (1C)." BCSH2010</p>
                <p>2. "As granulocytes cannot be leucodepleted and is usually given to immunocompromised patients, it is essential that the product be irradiated prior to transfusion to avoid graft-versus-host disease." UKBTS2012</p>
                <p>3. "Granulocyte components should continue to be provided as CMV seronegative for CMV seronegative patients." SABTO2012</p>
                <p>4. "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired)." SABTO2012</p>
              </td>
            </tr>
            <tr class="bloodcomponent">
              <td>3. Human Leucocyte Antigen (HLA)-selected components.</td>
              <td class="centered" data-value="3"><i class="fa fa-warning fa-3x red"></i>
              </td>
              <td class="centered" data-value="1"><i class="fa fa-square-o fa-3x green"></i> 
              </td>
              <td>"All human leucocyte antigen (HLA)-selected components should be irradiated, even if the patient is immunocompetent (2C)." BCSH2010</td>
            </tr>
            <tr class="bloodcomponent">
              <td>4. Fresh frozen plasma, cryoprecipitate or plasma derivative.</td>
              <td class="centered" data-value="1"><i class="fa fa-square-o fa-3x green"></i> 
              </td>
              <td class="centered" data-value="1"><i class="fa fa-square-o fa-3x green"></i> 
              </td>
              <td>It is not necessary to irradiate fresh frozen plasma, cryoprecipitate or fractionated plasma. CMV infection is associated with cellular blood components, such as red cells, platelets and granulocytes. Non-cellular components, such as fresh frozen plasma, cryoprecipitate and other plasma-derived blood components, do not need to be provided as CMV negative.</td>
            </tr>
            <tr class="bloodcomponent">
              <td>5. Red cells or platelets.</td>
              <td class="centered" data-value="2"><i class="fa fa-question-circle fa-3x amber"></i>
              </td>
              <td class="centered" data-value="2"><i class="fa fa-question-circle fa-3x amber"></i>
              </td>
              <td>Red cells and platelets contain lymphocytes (white cells) that can cause transfusion-associated Graft versus Host Disease (TA-GvHD). Cryopreserved red cells after deglycerolization do not require irradiation because they are washed free of leucocytes. Irradiated platelets and red cells are only indicated when there is an elevated risk of TA-GvHD.</td>
            </tr>
            <tr class="drugs">
              <td>6. Purine analogue drugs.</td>
              <td class="centered" data-value="3"><i class="fa fa-warning fa-3x red"></i>
              </td>
              <td class="centered" data-value="1"><i class="fa fa-square-o fa-3x green"></i>
              </td>
              <td>Red cells and platelets contain lymphocytes (white cells) that can cause transfusion-associated Graft versus Host Disease (TA-GvHD). Cryopreserved red cells after deglycerolization do not require irradiation because they are washed free of leucocytes. Irradiated platelets and red cells are only indicated for at-risk patients.</td>
            </tr>
            <tr class="drugs">
              <td>7. Campath (Alemtuzumab).</td>
              <td class="centered" data-value="3"><i class="fa fa-warning fa-3x red"></i>
              </td>
              <td class="centered" data-value="1"><i class="fa fa-square-o fa-3x green"></i>
              </td>
              <td>Red cells and platelets contain lymphocytes (white cells) that can cause transfusion-associated Graft versus Host Disease (TA-GvHD). Cryopreserved red cells after deglycerolization do not require irradiation because they are washed free of leucocytes. Irradiated platelets and red cells are only indicated for at-risk patients.</td>
            </tr>
            <tr class="drugs">
              <td>8. Anti-thymocyte globulin (ATG).</td>
              <td class="centered" data-value="3"><i class="fa fa-warning fa-3x red"></i>
              </td>
              <td class="centered" data-value="1"><i class="fa fa-square-o fa-3x green"></i>
              </td>
              <td>Red cells and platelets contain lymphocytes (white cells) that can cause transfusion-associated Graft versus Host Disease (TA-GvHD). Cryopreserved red cells after deglycerolization do not require irradiation because they are washed free of leucocytes. Irradiated platelets and red cells are only indicated for at-risk patients.</td>
            </tr>
          </tbody>
        </table>
        <hr/>
        <h2>Legend</h2>
        <h3><i class="fa fa-tint"></i> Blood components</h3>
        <h3><i class="fa fa-toggle-on"></i> Immunesuppressive drugs</h3>
        <h3><i class="fa fa-calendar-o"></i> Medical history</h3>
        <h3><i class="fa fa-child"></i> Neonatology and obstetrics</h3>
        <h3><i class="fa fa-eyedropper"></i> Stem cell and bone marrow transplant</h3>
        <br/>
        <br/>
        <br/>
        <br/>
        <br/>
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
       <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab inactive"><i class="fa fa-2x">&#xf19d;</i><br/>Learn</a>
            </li>
            <li><a href="#indications" class="navtab active"><i class="fa fa-ln fa-2x glow">&#xf02d;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    <div data-title="Special Blood Components" data-role="panel" id="searchpanel" data-position="right" data-display="overlay" data-theme="a">
      <h3 style="margin: 0px;" class="centered">Search the app</h3>
      <label for="searchfield">Enter a search term or look up a word in the index:</label>
      <input data-theme="a" type="search" name="searchfield" id="searchfield" value="">
      <select data-theme="a" id="glossarylist" name="glossarylist" data-inline="true">
        <option value="">Press to show index terms</option>
        <option value="atrisk">At-risk patients</option>
        <option value="cellular">Blood components, cellular</option>
        <option value="non-cellular">Blood components, non-cellular</option>
        <option value="cmv">Cytomegalovirus</option>
        <option value="relative">First-degree relative</option>
        <option value="tagvhd">Graft vs. Host Disease</option>
        <option value="irradiation">Irradiation</option>
        <option value="ld">Leucodepletion</option>
        <option value="causes">Mistakes, causes of</option>
        <option value="mistakes">Mistakes, frequency of</option>
        <option value="prevention">Mistakes, preventing</option>
        <option value="relative">Second-degree relative</option>
        <option value="special">Special blood component</option>
        <option value="uld">Universal leucodepletion</option>
      </select> <a href="#" data-rel="close" data-icon="delete" data-role="button">Close</a>
    </div>
    
    <script src="http://code.jquery.com/jquery-1.11.1.min.js"></script>
    <script>
    
      
      $(document).on("mobileinit", function() {
        $.mobile.defaultPageTransition = 'none';
        $.mobile.gradeA = function() {
          
          // return ( ( $.support.mediaquery && $.support.cssPseudoElement ) || $.mobile.browser.oldIE && $.mobile.browser.oldIE >= 8 ) && ( $.support.boundingRect || $.fn.jquery.match(/1\.[0-7+]\.[0-9+]?/) !== null );
          
          // hack to force ie7 support again
          return true;
        };
            
      });
    </script>
    <script src="http://code.jquery.com/mobile/1.4.4/jquery.mobile-1.4.4.min.js"></script>
    <script src="footable.js" type="text/javascript"></script>
    <script src="app.js"></script>
  </body>

</html>